Global Biosimilar Therapeutic Peptides Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends

2 Dec, 2021

Check out TBRC’s sale today for

The biosimilar therapeutic peptides market consists of sales of biosimilar therapeutic peptides by the companies that are engaged in developing and commercialization of biosimilar peptides drugs for therapeutic applications. Peptide drugs are used as replacement therapies which supplements peptide hormones when the endogenous levels tend to decrease. Biosimilar therapeutic peptides find its application in the treatment of cardiovascular diseases, metabolic diseases, respiratory conditions, cancer, and respiratory diseases.

Global Biosimilar Therapeutic Peptides Market Size And Drivers:

The global biosimilar therapeutic peptides market is expected to grow from $0.76 billion in 2020 to $0.87 billion in 2021 at a compound annual growth rate (CAGR) of 14.5%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The biosimilar therapeutic peptides market is expected to reach $2.25 billion in 2025 at a CAGR of 27%. The increasing aging population is projected to surge the patients with chronic diseases contributing to the biosimilar therapeutic peptides’ market growth.

Request For A Sample For The Global Biosimilar Therapeutic Peptides Market Report:

Trends In The Global Biosimilar Therapeutic Peptides Market

During the historic period, biosimilar therapeutic peptides market witnessed a growth in research collaborations as well as research funding approvals. Key companies are focusing on collaborations with companies and organizations to enhance their research & developments, expand their product portfolio, and geographical reach. For instance, in January 2020, a UK-based biotechnology company focusing on developing a class of therapeutics based on its proprietary bicyclic peptide technology announced a collaboration with Cancer Research UK to develop BT7401, a new bicycle immune-oncology candidate. Cancer Research UK will fund and sponsor the development of a new candidate. In addition to this, in April 2018, Sapience Therapeutics, Inc., a USA-based biotechnology company focused on research & development on peptide therapeutics announced a research collaboration with the University of Bath (UK) to develop and discover new therapeutic agents for oncology applications. Hence, research collaborations to develop new therapeutic peptides is a major trend in the market.

Global Biosimilar Therapeutic Peptides Market Segments:
The global biosimilar therapeutic peptides market is further segmented –
By Route Of Administration: Parenteral Route, Transdermal Route, Others
By Application: Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders
By Type: Innovative, Generic
By Geography: The global biosimilar therapeutic peptides market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Biosimilar Therapeutic Peptides Market At:

Biosimilar Therapeutic Peptides Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides biosimilar therapeutic peptides market overviews, analyzes and forecasts market size and growth for the global biosimilar therapeutic peptides market, biosimilar therapeutic peptides market share, biosimilar therapeutic peptides market players, biosimilar therapeutic peptides market segments and geographies, biosimilar therapeutic peptides market’s leading competitors’ revenues, profiles and market shares. The biosimilar therapeutic peptides market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Call Us

+1 3156230293


+44 2071930708


+91 8897263534

(Asia & Others)